Synchronization of cancer cell lines with methotrexate in vitro

Methods in Cell Science

Volumn 18, Issue 2, 1996, Pages 149-163

  Erba, Eugenio ^a   Sen, Soumitra ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Cancer cell lines; Cell synchronization; Flow cytometry; MTX

Indexed keywords

APHIDICOLIN; METHOTREXATE;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL KINETICS; CELL STRAIN K 562; CELL SYNCHRONIZATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LEUKEMIA L 1210;

MURINAE;

EID: 0029822880     PISSN: 13815741     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00122166     Document Type: Article

References (33)

1. Sen S, Erba E, D'Incalci M (1990). Synchronisation of cancer cell lines of human origin using methotrexate. Cytometry 11: 595-602.
2. Weiss A, Wiskocil RL, Stobo JD (1984). The role of T3 surface molecules in the activation of human T cells: A two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level. J Immunol 133: 123-128.
3. Lozzio CB, Lozzio BB (1975). Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 45: 321-334.
4. Sundstrom C, Nilsson K (1989). Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 17: 565-577.
5. Ubezio P, Filippeschi S, Spinelli L (1991). Method for kinetic analysis of drug-induced cell cycle perturbations. Cytometry 12: 119-126.
6. Fogh J, Fogh JM, Orfeo T (1977). One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 59: 221-225.
7. Erba E, Mascellani E, Pifferi A, D'Incalci M (1995). Comparison of cell-cycle phase perturbations induced by DNA-minor-groove alkylator tallimustine and by melphalan in the SW626 cell line. Int J Cancer 62: 170-175.
8. Erba E, Giordano M, Danova M, et al. (1994). Cell kinetics of human ovarian cancer with in vivo administration of bromodeoxyuridine. Ann Oncol 5: 627-634.
9. Krishan A, Frei E III (1976). Effect of adriamycin on the cell cycle traverse and kinetics of cultured human lymphoblasts. Cancer Res 36: 143-150.
10. Yunis JJ (1976). High resolution of human chromosomes. Science 1268-1270.
11. Espinoza B, Wharton W (1986). Effects of cholera toxin and isobutylmethylxantine on growth of human fibroblasts. Am J Physiol 251: 238-246.
12. Fox MH, Read RA, Bedford JS (1987). Comparison of synchronized chinese hamster ovary cells obtained by mitotic shake-off, hydroxyurea, aphidicolin, or methotrexate. Cytometry 8: 315-320.
13. Ikegami S, Taguchi T, Ohashi M, et al. (1978). Aphidicolin prevent mitotic cell division by interfering with the activity of DNA polimerase-α. Nature 275: 458-460.
14. Pedrali NG, Spadari S, Miller-Faures A, et al. (1980). Synchronization of HeLa cell cultures by inhibition of DNA polymerase alpha with aphidicolin. Nucleic Acids Res 8: 377-387.
15. 3H 10T1/2 cells synchronized by aphidicolin. Biochem 24: 4815-4822.
16. Tobey RA, Valdez JG, Crissman HA (1988). Synchronization of human diploid fibroblasts at multiple stages of the cell cycle. Exp Cell Res 179: 400-416.
17. D'Anna JA, Crissman HA, Jackson PJ, Tobey R (1985). Time-dependent changes in H1 content, H1 turnover, DNA elongation and the survival of cells blocked in early S phase by hydroxyurea, aphidicolin, or 5-fluorodeoxyuridine. Biochemistry 24: 5020-5026.
18. Lobbezoo MW, Winograd B, Pinedo HM, et al. (1987). Preclinical drug profile of aphidicolin glycinate (NSC-303812). Proc Am Ass Cancer Res 28: 311.
19. 10-propargyl-5, 8-dideazafolic acid. Cancer Res 48: 2036-2041.
20. Bunni M, Doig MT, Donato H, Kesavan V, Priest DG (1988). Role of methylenetetrahydrofolate depletion in methotrexate-mediated intracellular thymidylate synthesis inhibition in cultured L1210 cells. Cancer Res 48: 3398-3404.
21. Goldman ID, Matherly LH (1985). The cellular pharmacology of methotrexate. Pharmacol Ther 28: 77-102.
22. Jolivet J, Cowan KH, Curt GA, Clendeninn NJ, Chabner BA (1983). The pharmacology and clinical use of methotrexate. N Engl J Med 309: 1094-1104.
23. Moran RG, Mulkins M, Heidelberger C (1979). Role of thymidylate synthetase activity in development of methotrexate cytotoxicity. Proc Natl Acad Sci USA 76: 5924-5928.
24. Werkheiser WC (1963). The biochemical, cellular and pharmacological action and effects of the folic acid antagonist. Cancer Res 191: 1277-1285.
25. Kessel D, Hall TC, DeWayne R, Wodinsky I (1965). Uptake as a determinant of methotrexate response in mouse leukemias. Science 150: 752-753.
26. Bokkerink JPM, De Abreu RA, Bakker MAH, et al. (1986). Dose-related effects of methotrexate on purine and pyrimidine nucleotides and on cell-kinetic parameters in Molt-4 malignat human T-lymphoblasts. Biochem Pharmacol 35: 3557-3564.
27. Jackson RC (1984). Biological effects of folic acid antagonists with antineoplastic activity. Pharmacology 25: 61-82.
28. Tsurusawa M, Niwa M, Katano N, Fujimoto T (1988). Flow cytometric analysis by bromodeoxyuridine/DNA assay of cell cycle perturbation of methotrexate-treated mouse L1210 leukemia cells. Cancer Res 48: 4288-4293.
29. Jackson RC, Jackman AL, Calvert AH (1983). Biochemical effects of a quinazoline inhibitor of thymidilate synthetase, N-(4-(N-((2-amino-4-hydroxy-6-quinazolinyl)methyl) prop-2-ynylamino) benzoyl)-L-glutamic acid (CB3717), on human lymphoblastoid cells. Biochem Pharmacol 32: 3783-3790.
30. Crissman HA, Darzynkiewicz Z, Tobey RA, Steinkamp JA (1985). Normal and perturbated Chinese hamster ovary cells: Correlation of DNA, RNA, and protein content by flow cytometry. J Cell Biol 101: 141-147.
31. Darzynkiewicz Z, Evenson DP, Staiano-Coico L, Sharpless TK, Melamed ML (1979). Correlation between cell cycle duration and RNA content. J Cell Physiol 100: 425-438.
32. Traganos F, Darzynkiewicz Z, Melamed ML (1982). The ratio of RNA to total nucleic acid content as a quantitative measure of unbalanced cell growth. Cytometry 2: 212-218.
33. Fairchild CR, Maybaum J, Straw JA (1988). Enhanced cytotoxicity with methotrexate in conjunction with hypoxanthine in L1210 cells in culture. Cancer Chemother Pharmacol 22: 26-32.